Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
mylan pharmaceuticals
28 tablet
Sofosbuvir (400 mg)
Keep in cold place
Delivering To:
Overview
Myhep 400mg Tablet is a prescription-based antiviral medicine. It is used in the treatment of chronic Hepatitis C virus (HCV) infection. It contains Sofosbuvir (400mg) as an active ingredient, which works by reducing the amount of hepatitis C virus in the body and helps the liver to recover. It is usually taken in combination with other antiviral medicines to get an effective result.
Hepatitis C
Most side effects of Myhep 400mg Tablet do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Common side effect include :
Fatigue or tiredness
Headache
Nausea
Insomnia (trouble sleeping)
Mild irritability
Some serious side effects :
Yellowing of the eyes or skin (jaundice)
Dark urine or pale stools
Shortness of breath or dizziness
Unusual bleeding or bruising
Inform your doctor immediately if you experience any persistent or unusual side effect.
The required dosage and duration of Myhep 400mg Tablet is decided by the doctor as per medical history, age, health condition, and the body's response to the treatment. It is a prescription-based hepatitis drug that should be administered orally. It is advised to take this tablet with or without food as per the doctor's advice. It should be taken at the same time every day for effective results. Taking it in the wrong way or overdosing can cause severe side effects. It may take weeks for patients to notice the benefits of the medicine. So do not stop taking this tablet without informing the doctor.
Alcohol
unsafe
Avoid the consumption of alcohol while taking Myhep 400mg Tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Do not take the Myhep 400mg Tablet without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
consult your doctor
Myhep 400mg Tablet is dangerous to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Myhep 400mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Consumption of Myhep 400mg Tablets usually safe in mild to moderate kidney problem and should be avoided without informing the doctor if you have any severe kidney-related issues.
Liver
caution
Consumption of Myhep 400mg Tablet Safe and beneficial when prescribed by the doctor otherwise should be avoided without informing the doctor if you have any liver-related
It is suggested you that do not skip your medicines. If you forget to take your medication then contact your doctor immediately.
Myhep 400mg is prescribed to treat chronic hepatitis C (HCV) infection by reducing the virus level in the body and improving liver function.
Yes, when taken in combination with other antivirals as prescribed, this tablet can completely cure hepatitis C by eliminating the Hepatitis C virus from the body in most patients.
Most people begin to see benefits of the medicine within 12 weeks, though some may need up to 24 weeks it totally depends on patient's health condition.
Avoid the consumption of Alcohol as it can reduce treatment effectiveness and cause further liver damage.
Take it as soon as you remember but don't overdose the tablet.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1. Maung, S. T., Bwa, A. H., Win, S. T. S., Htar, S. S., Han, K. A. W., Oo, M. P., ... & Win, K. M. (2021). Efficacy of Fixed-dose Combination of Sofosbuvir and Ledipasvir (SOF/LDV)±Ribavirin (RBV) in Patients (n= 130) Infected with HCV Genotype 6 (Real World Myanmar Experience). Greater Mekong Subregion Medical Journal, 1(1), 1-10.
2. Rangari, S. W., & Bari, S. B. Quantitative Determination Of Sofosbuvir In Pure And Pharmaceutical Dosages Form By ATR-FTIR Spectroscopic As A Green Method.
3. Sirinawasatien, A., & Techasirioangkun, T. (2020). Sofosbuvir-based regimens in the treatment of patients with chronic hepatitis C virus infection: Real-world efficacy in Thailand. PLoS One, 15(2), e0229517.
4. Ali, R. A., Awadalla, E. A., Amin, Y. A., Fouad, S. S., Ahmed, M. A. E. B., Hassan, M. H., ... & Abdel-Aziz, R. H. (2024). The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes. Scientific Reports, 14(1), 5682.
5. Cada, D. J., Cong, J., & Baker, D. E. (2014). Sofosbuvir. Hospital Pharmacy, 49(5), 466-478.
mylan pharmaceuticals
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.